Last updated: 10 June 2024 at 4:40pm EST

Dannielle Appelhans Net Worth




The estimated Net Worth of Dannielle Appelhans is at least $425 mil dollars as of 8 December 2023. Ms Appelhans owns over 8,000 units of Rubius Therapeutics Inc stock worth over $611 and over the last 3 years she sold RUBY stock worth over $1,350. In addition, she makes $422,980 as Chief Operating Officer at Rubius Therapeutics Inc.

Ms Appelhans RUBY stock SEC Form 4 insiders trading

Ms has made over 5 trades of the Rubius Therapeutics Inc stock since 2022, according to the Form 4 filled with the SEC. Most recently she bought 8,000 units of RUBY stock worth $14,320 on 8 December 2023.

The largest trade she's ever made was exercising 12,500 units of Rubius Therapeutics Inc stock on 9 August 2022 worth over $1,038. On average, Ms trades about 5,039 units every 49 days since 2021. As of 8 December 2023 she still owns at least 7,363 units of Rubius Therapeutics Inc stock.

You can see the complete history of Ms Appelhans stock trades at the bottom of the page.





Ms. Dannielle Appelhans biography

Dannielle Appelhans is the Chief Operating Officer at Rubius Therapeutics Inc.

What is the salary of Ms Appelhans?

As the Chief Operating Officer of Rubius Therapeutics Inc, the total compensation of Ms Appelhans at Rubius Therapeutics Inc is $422,980. There are 7 executives at Rubius Therapeutics Inc getting paid more, with Pablo Cagnoni having the highest compensation of $1,721,130.



How old is Ms Appelhans?

Ms Appelhans is 38, she's been the Chief Operating Officer of Rubius Therapeutics Inc since . There are 18 older and no younger executives at Rubius Therapeutics Inc. The oldest executive at Rubius Therapeutics Inc is Michael Rosenblatt, 69, who is the Independent Director.

What's Ms Appelhans's mailing address?

Dannielle's mailing address filed with the SEC is C/O GENERATION BIO CO., 301 BINNEY ST, , CAMBRIDGE, MA, 02142.

Insiders trading at Rubius Therapeutics Inc

Over the last 6 years, insiders at Rubius Therapeutics Inc have traded over $2,165,279 worth of Rubius Therapeutics Inc stock and bought 305,000 units worth $6,624,680 . The most active insiders traders include Noubar Afeyan, Roger Pomerantz, eRobert Langer. On average, Rubius Therapeutics Inc executives and independent directors trade stock every 51 days with the average trade being worth of $2,709. The most recent stock trade was executed by Dannielle Appelhans on 24 February 2023, trading 10,385 units of RUBY stock currently worth $1,350.



What does Rubius Therapeutics Inc do?

developing a novel enucleated cell (ecell)(tm) therapy platform for unmet medical needs. founded by flagship venturelabs.



What does Rubius Therapeutics Inc's logo look like?

Rubius Therapeutics Inc logo

Complete history of Ms Appelhans stock trades at Rubius Therapeutics Inc e Generation Bio Co

Data
#
Companhia
Acionista maioritário
Trans.
Transação
Ações Preço por ação Preço total Ações após Fonte
8 Dec 2023 Dannielle Appelhans
Comprar 8,000 $1.79 $14,320
8 Dec 2023
7,363
4 Dec 2023 Dannielle Appelhans
Comprar 12,000 $1.50 $18,000
4 Dec 2023
12,000
24 Feb 2023 Dannielle Appelhans
Chefe Executivo e Presidente
Venda 10,385 $0.13 $1,350
24 Feb 2023
0
31 Jan 2023 Dannielle Appelhans
Chefe Executivo e Presidente
Exercício de opção 7,500 $0.26 $1,954
31 Jan 2023
14,263
9 Aug 2022 Dannielle Appelhans
Chefe Executivo e Presidente
Exercício de opção 12,500 $0.80 $10,000
9 Aug 2022
12,500


Rubius Therapeutics Inc executives and stock owners

Rubius Therapeutics Inc executives and other stock owners filed with the SEC include: